Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27

Exclusion Criteria

• •Patients unwilling.
• •Patient participating in another study.
• •Patients with cardiogenic shock
• •Patient on anti GpIIbIIIa or stopped less than 72 hours before the test aggregability
• •Patients scheduled for surgery in less than 6 months
• •ischemic stroke older than 6 weeks.
• •History of hemorrhagic stroke (any time)
• •Patients on or candidates for AVK
• •Patients with a different anti ADP (ticlopidine, prasugrel)
• •Patients with an indication against clopidogrel (side effects, bleeding ...)
• •Thrombocytopenia \< 100000/mm3
• •anemia (Ht \< 30%)
• •Thrombocythaemia (Ht \> 52%)
• •Pregnancy